1.Infantile tetramine poisoning treated with sodium dimercaptosulfonate: clinical analysis of 54 cases.
Chinese Journal of Pediatrics 2003;41(12):948-949
Adolescent
;
Antidotes
;
therapeutic use
;
Bridged-Ring Compounds
;
poisoning
;
Child
;
Child, Preschool
;
Female
;
Follow-Up Studies
;
Humans
;
Infant
;
Male
;
Poisoning
;
mortality
;
therapy
;
Survival Rate
;
Treatment Outcome
;
Unithiol
;
therapeutic use
2.Risk factors of early postoperative high intraocular pressure after improved 23 -gauge vitrectomy
Xue-Mei, LIANG ; Jing-Jing, LI ; Bin, QIN
International Eye Science 2014;(9):1649-1651
To observe the incidence of high intraocular pressure ( lOP ) and its risk factors in the early stage (within 7d) after 23 - gauge sutureless microincisional vitrectomy.
●METHODS: Retrospective case series study. Totally 98 patients ( 98 eyes ) who had undergone 23 - gauge sutureless microincisional vitrectomy were enrolled. lOP was measured by non-contact tonometry. High lOP was defined as an lOP > 25mmHg at any time within 7d after surgery. The influence of age, sex, side of operation, course of disease, primary disease pre - operation, reoperation, surgical options, type of tamponade, status of lens, surgical time on postoperative high lOP were analyzed.
● RESULTS: High lOP was found in 33 eyes ( 33. 7%) within 7d after surgery. High lOP was found in 8 eyes on postoperative 1d, the incidence was 24. 2% (8 / 33), and 25 eyes was found on postoperative 3d, the incidence was 75. 8% (25 / 33). The incidence of high lOP of male and female were 32. 8% ( 20 / 61 ) and 35. 1% ( 13 / 37 ) respectively. The incidence of high lOP of right and left eye were 36. 8% (21 / 57) and 29. 3% (12 / 41) respectively. There were no significant differences comparing age (Z =-0. 22), sex( χ2 = 0. 057), side of operation( χ2 = 0. 612), course of disease (Z= -0.079) and surgical time (Z= -0. 553) between patients with high lOP and those without it (P>0. 05). Similarly, no statistical significance was found between eyes with gas tamponade and silicone oil tamponade (χ2 = 1. 04), traumatic eyes and non traumatic eyes(χ2 = 0. 044), and retinal detachment eyes and without retinal detachment eyes ( χ2 = 2. 282, P > 0. 05 ). The incidence of high lOP in eyes with several operations was higher than that in eyes with the first operation ( χ2 =5. 211,P< 0. 05), in eyes with combined operations eyes was significantly higher than that in eyes with pure vitrectomy (χ2 = 4. 57,P< 0. 05), and in eyes with aphakic eye was higher than that in eyes with phakic eyes ( χ2 =4. 224,P<0. 05).
●CONCLUSlON:High lOP occurs commonly in 3d after 23- gauge sutureless microincisional vitrectomy. The risk factors of high lOP are reoperation, combined operations and aphakic eye.
4.Changes and Significances of Serum Leptin and Interleukin-1? before and after Treatment with Risperidone in Children with Schizophrenics
xue-qin, SONG ; jing-ping, ZHAO ; lu-xian, LV
Journal of Applied Clinical Pediatrics 2004;0(08):-
Objective To explore the changes and significances of serum leptin and interleukin-1?(IL-1?)before and after treatment with risperidone in children with schizophrenics.Methods Thirty-one cases with first-episode children with schizophrenia were chosen in patient group.Their body weight and height were measured before and 8 weeks after treatment with risperidone to calculate the body mass index(BMI),and their fasting serum leptin and IL-1? were assayed radio-immunity method.Thirty-one healthy controls were measured at the same time.Results BMI and the level of serum leptin in patients of post-treatment increased significantly compared with those of pre-treatment(all P
6.A sandwich method of enzyme immunoassay for serum FT_4
Hong ZHENG ; Xue-Qin ZHAO ; Jing-Yu ZHANG ;
Chinese Journal of Endocrinology and Metabolism 2000;0(06):-
T_4 was coupled to human serum albumin(HSA)to make the conjugate T_4-HSA,a polyvalent T_4 analogue rather than monovalent T_4 per se alone.A new strategy for sandwich enzyme immunoassay model system of small molecular hapten hormones FT_4 was developed,such as intra-assay CV,inter-assay CV,average recovery, normal and abnormal values were fit for clinical application.The sensitivity was as much as 10 times higher than conventional competitive enzyme immunoassay.
7.Subtype classification of ceftriaxone sodium and its influence on the quality of product.
Jing XUE ; Yan-Hua JIA ; Jin LI ; Li-Hui YIN ; Chang-Qin HU
Acta Pharmaceutica Sinica 2014;49(7):1034-1038
Powder X-ray diffraction (PXRD) technology combined with cluster analysis method was used to classify 75 batches of crystalline ceftriaxone sodium into subtypes, the crystalline characteristics of each subtype were measured with scanning electron microscope (SEM). By comparing some parameters of these subtypes correlated to crystallization process of ceftriaxone sodium, such as salification rate, water content in different subtypes, as well as by studying different lattice stabilities, different compatibilities with rubber closures during accelerated stability tests, the key point to improve the quality of domestic ceftriaxone sodium was disclosed. The results of this paper indicated that the fine structure of the products could be controlled well by improving the salification and crystallization process. As a result, the subtype II of ceftriaxone sodium with high stability can be produced.
Ceftriaxone
;
chemistry
;
classification
;
Crystallization
;
Microscopy, Electron, Scanning
;
Powders
;
Water
;
X-Ray Diffraction
8.Identification and function of the growth hormone gene in Rongjiang pig of China.
Jing LI ; Xue-Qin RAN ; Jia-Fu WANG
Acta Physiologica Sinica 2006;58(3):217-224
Growth of animal is largely regulated by growth hormone (GH). In this study, the GH gene was isolated and cloned from the genomic DNA library from Rongjiang pig, a Chinese local swine, using polymerase chain reaction technique. The complete nucleotide sequence of a 1.903 kb genomic fragment containing Rongjiang swine GH gene has been determined. The GH gene contained five exons and four introns similar to the GH genes of other mammalians and exhibited 97%~99% identity to the GH genes of the four western meat-type breeds and nine Chinese local pigs. Polymorphism of GH genes was analyzed by using the restriction enzymes Dde I, Nar I and BsmN I in four western meat-type breeds and ten Chinese local pigs. Five polymorphic restriction sites, with Dde I at the base 622 (G/A) in exon 2 and 274 (T/C) in 5o-flank, with Nar I at 631 (G/A) in exon 2, and with BsmN I at the base 841 (T/C) in intron 2 and 1358 (A/G) in exon 4, were identified. The polymorphic restriction site at 1358 (A/G) leaded to the GH mature protein of Rongjiang pig differing from that of four western meat-type breeds and eight Chinese local breeds at the residue Val108 substituted by Ile108. According to the crystal structure of human GH mature protein, this Ile108 substitution might result in a lower affinity of GH for its receptor in Rongjiang breed.
Animals
;
Breeding
;
China
;
Cloning, Molecular
;
Exons
;
Growth Hormone
;
genetics
;
physiology
;
Introns
;
Polymerase Chain Reaction
;
Polymorphism, Genetic
;
Polymorphism, Restriction Fragment Length
;
Species Specificity
;
Swine
9.Analysis of personality characteristics and psychological situation of children suffered from nephrotic syndrome of school age
Qiang HE ; Zhi-Qin LIAO ; Jing-Hong YU ; Xue-Hua LI ;
Chinese Journal of Primary Medicine and Pharmacy 2006;0(07):-
Objective To analyze personality characteristics and psychological situation of children suffered from nephrotic syndrome of school age,and to provide clinical evidence for the children patients to be interfered fur- ther by psychological act.Methods EPQ,SAS and SDS were used to survey the personality and psychology of 30 cases of children suffered from nephrotic syndrome of school age and 28 cases of children who were in normal school age as statistic calculation comparison.Results The score of N,P,L inventory for the children suffered from nephrotie syndrome of school age was higher,and the score of E inventory was lower,which all had remarkably(P
10.Expression of cancer-testis antigen in multiple myeloma.
Li, HE ; Jing-na, JI ; Shang-qin, LIU ; Er, XUE ; Qing, LIANG ; Zi, MA
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(2):181-5
Recently, the immunotherapy has been highlighted among cancer treatments. Cancer-testis antigen (CTA) has been studied in a variety of solid tumors because of its specific expression in tumors, and testis, ovary and placenta tissues, but not in other normal tissues. In order to provide a new approach for multiple myeloma (MM) immunotherapy, we examined the CTA expression in MM cell lines, and primary myeloma cells in patients with MM. Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the mRNA expression of MAGE-C1/CT7, SSX1, SSX2 and SSX4 in MM cell lines of RPMI-8226 and U266, and bone marrow (BM) cells of 25 MM patients and 18 healthy volunteers. The results showed that the 4 CTAs were expressed in RPMI-8226 and U266 cell lines. The positive expression rate of MAGE-C1/CT7, SSX1, SSX2 and SSX4 in the BM cells of 25 MM patients was 28% (7/25), 80% (20/25), 40% (10/25) and 68% (17/25), respectively. In contrast, the expression of any member of the CTAs was not detected in BM cells of 18 healthy volunteers. The expression of two or more CTAs was detected in 80% (20/25) MM patients, and that of at least one CTA in 88% (22/25). The mRNA expression levels of SSX1 and SSX4 were significantly higher in patients with MM at stage III than in those at stage I and II (P<0.05). No statistically significant differences were observed in the mRNA expression levels of MAGE-C1/CT7 and SSX2 in further stratified analyses by age, gender, MM types and percentage of MM cells in BM (P>0.05). In conclusion, our present study showed that MAGE-C1/CT7, SSX1, SSX2 and SSX4 were co-expressed in MM cell lines and the primary myeloma cells in MM patients, but not expressed in BM cells of healthy subjects. The mRNA levels of SSX1 and SSX4 are associated with MM clinical stage. This work may provide a new insight into MM immunotherapy in the future.